215 related articles for article (PubMed ID: 27558979)
1. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.
Mundal L; Igland J; Ose L; Holven KB; Veierød MB; Leren TP; Retterstøl K
Eur J Prev Cardiol; 2017 Jan; 24(2):137-144. PubMed ID: 27794106
[TBL] [Abstract][Full Text] [Related]
3. Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
Mundal LJ; Igland J; Veierød MB; Holven KB; Ose L; Selmer RM; Wisloff T; Kristiansen IS; Tell GS; Leren TP; Retterstøl K
Heart; 2018 Oct; 104(19):1600-1607. PubMed ID: 29622598
[TBL] [Abstract][Full Text] [Related]
4. Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study.
Mundal LJ; Igland J; Leren TP; Retterstøl K
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):712-713. PubMed ID: 33485759
[No Abstract] [Full Text] [Related]
5. Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.
Mundal L; Sarancic M; Ose L; Iversen PO; Borgan JK; Veierød MB; Leren TP; Retterstøl K
J Am Heart Assoc; 2014 Dec; 3(6):e001236. PubMed ID: 25468658
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolaemia: the Cape Town experience.
Firth JC; Marais AD
S Afr Med J; 2008 Feb; 98(2):99-104. PubMed ID: 18350202
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
Iyen B; Qureshi N; Kai J; Akyea RK; Leonardi-Bee J; Roderick P; Humphries SE; Weng S
Atherosclerosis; 2019 Aug; 287():8-15. PubMed ID: 31181417
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study.
Toleikyte I; Retterstøl K; Leren TP; Iversen PO
Circulation; 2011 Oct; 124(15):1606-14. PubMed ID: 21911783
[TBL] [Abstract][Full Text] [Related]
9. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
Elis A; Zhou R; Stein EA
Cardiol Young; 2014 Jun; 24(3):437-41. PubMed ID: 23659280
[TBL] [Abstract][Full Text] [Related]
10. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
11. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
[TBL] [Abstract][Full Text] [Related]
12. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
[TBL] [Abstract][Full Text] [Related]
13. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
[TBL] [Abstract][Full Text] [Related]
14. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
Kastelein JJ; Besseling J; Shah S; Bergeron J; Langslet G; Hovingh GK; Al-Saady N; Koeijvoets M; Hunter J; Johnson-Levonas AO; Fable J; Sapre A; Mitchel Y
Lancet; 2015 May; 385(9983):2153-61. PubMed ID: 25743173
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.
Alonso R; Mata N; Castillo S; Fuentes F; Saenz P; Muñiz O; Galiana J; Figueras R; Diaz JL; Gomez-Enterría P; Mauri M; Piedecausa M; Irigoyen L; Aguado R; Mata P;
Atherosclerosis; 2008 Oct; 200(2):315-21. PubMed ID: 18243212
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records.
Iyen B; Qureshi N; Weng S; Roderick P; Kai J; Capps N; Durrington PN; McDowell IF; Soran H; Neil A; Humphries SE
Atherosclerosis; 2020 Dec; 315():131-137. PubMed ID: 33187671
[TBL] [Abstract][Full Text] [Related]
17. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
18. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
[TBL] [Abstract][Full Text] [Related]
19. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.
Bhatnagar D; Morgan J; Siddiq S; Mackness MI; Miller JP; Durrington PN
BMJ; 2000 Dec; 321(7275):1497-500. PubMed ID: 11118175
[TBL] [Abstract][Full Text] [Related]
20. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
